Curanex Pharmaceuticals Inc (CURX)
(Delayed Data from NSDQ)
$1.25 USD
-0.27 (-17.49%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $1.24 -0.01 (-0.80%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CURX 1.25 -0.27(-17.49%)
Will CURX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CURX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CURX
12 Health Care Stocks Moving In Thursday's Intraday Session
Is CURX signaling selling opportunity? New 52 Week Closing Low shows up after tumbling 83.46%
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Wednesday's Intraday Session